Boston Scientific Corporation (BSX) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 141.16B |
| Enterprise Value | 151.53B |
| P/E Ratio | 17.3 |
| PEG Ratio | 0.38 |
| Price/Sales Ratio | 3.04 |
| Price/Book Ratio | 2.54 |
| Enterprise/Revenue | 3.61 |
| Enterprise/EBITDA | 13.36 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
| Profit Margin | 0.17 |
| Operating Margin | 0.21 |
| Return On Assets | 0.08 |
| Return On Equity | 0.15 |
| Revenue | 20.07B |
| Revenue/Share | 14.21 |
| Gross Profit | 13.85B |
| EBITDA | 5.1B |
| Net Income | 2.89B |
| Diluted EPS | 1.94 |
| Total Cash | 539M |
| Total Cash/Share | 0.36 |
| Total Debt | 12.62B |
| Total Debt/Equity | 0.51 |
| Current Ratio | 1.24 |
| Book Value Per Share | 17.04 |
| 52-Week Change | -58.87 |
| 52-Week High | 105.65 |
| 52-Week Low | 42.2 |
| Moving Average 50 Days | 46.94 |
| Moving Average 200 Days | 65.96 |
| Average Volume | 20M |
| Shares Outstanding | 1.49B |
| % Held by Institutions | 90.61 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 2:1 |
| Last Split Date | November 06, 2003 |